NPPA Asks State, UT Govts to Ensure Availability of PPEs, Masks, Testing Kits And Ventilators

The National Pharmaceutical Pricing Authority (NPPA) on Wednesday asked the state and UT governments to ensure availability of essential medical equipment such as personal protective equipments (PPEs), masks, gloves, testing kits and ventilators.

In a letter to the chief secretaries of all state and UT governments, NPPA Chairperson Shubhra Singh said the government has notified all drugs as medical devices.

According to letter, “all medical devices (around 5,000 devices) have come under the jurisdiction of regulatory supervision for quality control and price monitoring. This is a major tool in fight with the emerging situation due to COVID-19,”

The letter asked them to provide by April 5 the production capacity of these medical devices in the state and number of procurement orders issued by the state government, government hospitals, other healthcare establishments, state public sector undertakings, co-operatives and private health services. It has also asked the chief secretaries to provide stock-in-hand at government hospitals, other healthcare establishments, state public sector undertakings, co-operatives and private health services.

Further, it asked them to provide details about stock-in-hand at retailers level and action to be taken by state government to meet out the emerging requirement in response to COVID-19.

The letter asked them to assess the requirements of state governments for PPEs, masks, gloves and ventilators for next two months, their current availability, shortfall and proposal to address shortage

  • Related Posts

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta launches EVERQ, AI-powered skin-health platform

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell therapy for autism only in approved clinical trials: Centre